[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL1812448T3 - Związki organiczne - Google Patents

Związki organiczne

Info

Publication number
PL1812448T3
PL1812448T3 PL05803350T PL05803350T PL1812448T3 PL 1812448 T3 PL1812448 T3 PL 1812448T3 PL 05803350 T PL05803350 T PL 05803350T PL 05803350 T PL05803350 T PL 05803350T PL 1812448 T3 PL1812448 T3 PL 1812448T3
Authority
PL
Poland
Prior art keywords
organic compounds
compounds
organic
Prior art date
Application number
PL05803350T
Other languages
English (en)
Inventor
Pascale Hoehn
Bernd Koch
Michael Mutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35501294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1812448(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1812448T3 publication Critical patent/PL1812448T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL05803350T 2004-11-05 2005-11-03 Związki organiczne PL1812448T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62534304P 2004-11-05 2004-11-05
US64213105P 2005-01-07 2005-01-07
PCT/EP2005/011789 WO2006048296A1 (en) 2004-11-05 2005-11-03 Organic compounds
EP05803350A EP1812448B1 (en) 2004-11-05 2005-11-03 Organic compounds

Publications (1)

Publication Number Publication Date
PL1812448T3 true PL1812448T3 (pl) 2012-10-31

Family

ID=35501294

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05803350T PL1812448T3 (pl) 2004-11-05 2005-11-03 Związki organiczne

Country Status (31)

Country Link
US (2) US8198435B2 (pl)
EP (3) EP1812448B1 (pl)
JP (4) JP5057986B2 (pl)
KR (3) KR101333851B1 (pl)
CN (2) CN102993213A (pl)
AR (1) AR052322A1 (pl)
AU (2) AU2005300693B2 (pl)
BR (1) BRPI0517689A (pl)
CA (1) CA2584911C (pl)
CY (1) CY1113059T1 (pl)
DK (1) DK1812448T3 (pl)
EC (1) ECSP12007431A (pl)
ES (1) ES2388142T3 (pl)
GT (1) GT200500311A (pl)
HK (2) HK1211587A1 (pl)
HR (1) HRP20120652T1 (pl)
IL (3) IL182691A (pl)
JO (1) JO2897B1 (pl)
MA (1) MA29033B1 (pl)
MX (2) MX346525B (pl)
MY (2) MY154878A (pl)
NO (2) NO338960B1 (pl)
NZ (3) NZ554653A (pl)
PE (3) PE20130377A1 (pl)
PL (1) PL1812448T3 (pl)
PT (1) PT1812448E (pl)
RU (2) RU2394038C2 (pl)
SI (1) SI1812448T1 (pl)
TN (1) TNSN07165A1 (pl)
TW (4) TWI455941B (pl)
WO (1) WO2006048296A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007013567D1 (de) * 2006-08-16 2011-05-12 Novartis Ag Verfahren zur herstellung fester dispersionen von midostaurin
EP2327706A1 (en) * 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
KR20160008267A (ko) 2014-07-14 2016-01-22 주식회사 윈스 네트워크 기반 영상감시체계에서의 사용자 행위 분석 시스템
US20200010481A1 (en) 2017-03-06 2020-01-09 Teva Pharmaceutical Works Ltd. Solid state forms of midostaurin
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
IT201900004729A1 (it) 2019-03-29 2020-09-29 Procos Spa Processo per la preparazione di midostaurina ad elevato grado di purezza
WO2020261293A1 (en) * 2019-06-24 2020-12-30 Dr. Reddy's Laboratories Limited Process for preparation of midostaurin
IT201900014346A1 (it) 2019-08-08 2021-02-08 Procos Spa Processo per la preparazione di midostaurina amorfa con un basso contenuto di solvente organico residuo
IT202000004291A1 (it) 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN111393454A (zh) * 2020-05-07 2020-07-10 奥锐特药业(天津)有限公司 米哚妥林的新晶型及其制备方法
CN115124551B (zh) * 2021-03-24 2024-04-30 奥锐特药业(天津)有限公司 一种高纯度米哚妥林的制备方法
WO2023205504A1 (en) * 2022-04-22 2023-10-26 Rutgers, The State University Of New Jersey Formulations and methods for treating epidermolysis bullosa simplex and related conditions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS60185719A (ja) 1984-03-06 1985-09-21 Ajinomoto Co Inc 抗腫瘍剤
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5093330A (en) 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
US5073633A (en) 1989-03-23 1991-12-17 Bristol-Myers Company BMY-41950 antitumor antibiotic
US5096330A (en) * 1990-06-21 1992-03-17 M-B-W Inc. Pitch control mechanism for a surface finishing machine
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
JPH05247955A (ja) 1992-03-06 1993-09-24 Taisei Corp 擁壁の施工方法
ES2136103T3 (es) 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
AU2565895A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
JP4070810B2 (ja) 1995-12-11 2008-04-02 セファロン・インコーポレイテッド タンパク質キナーゼcの阻害剤としての縮合イソインドロン
EP1214336A1 (en) * 1999-08-30 2002-06-19 Universität Zürich Synthesis of template-fixed beta-hairpin loop mimetics
DE60211494T2 (de) 2001-03-26 2006-10-12 Novartis Ag Pharmazeutische zusammensetzung enthaltend ein schlecht wasserlösliches staurosporin, eine oberflächenaktive substanz und ein wasserlösliches polymer
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
WO2004094645A1 (en) * 2003-04-22 2004-11-04 Lonza Ag Process for the recovery of staurosporine from a fermentation broth

Also Published As

Publication number Publication date
CN102993213A (zh) 2013-03-27
US20090137552A1 (en) 2009-05-28
IL182691A (en) 2013-02-28
CA2584911C (en) 2017-10-24
AU2005300693A1 (en) 2006-05-11
CN102627658A (zh) 2012-08-08
AU2009245817A1 (en) 2009-12-24
TW201247680A (en) 2012-12-01
JP5701246B2 (ja) 2015-04-15
AU2005300693B2 (en) 2010-08-19
EP2955186A1 (en) 2015-12-16
WO2006048296A1 (en) 2006-05-11
IL207702A0 (en) 2010-12-30
HRP20120652T1 (hr) 2012-09-30
ECSP12007431A (es) 2012-06-29
IL182691A0 (en) 2007-09-20
TW200628474A (en) 2006-08-16
MX2007005429A (es) 2007-05-18
MX346525B (es) 2017-03-23
NO340404B1 (no) 2017-04-18
EP2272850A3 (en) 2011-09-21
EP1812448B1 (en) 2012-05-23
PE20060947A1 (es) 2006-10-30
HK1211587A1 (en) 2016-05-27
KR101265850B1 (ko) 2013-05-20
HK1108881A1 (en) 2008-05-23
RU2467012C2 (ru) 2012-11-20
TW201446773A (zh) 2014-12-16
MY147404A (en) 2012-11-30
TWI530501B (zh) 2016-04-21
RU2009137788A (ru) 2011-04-20
TW201247681A (en) 2012-12-01
US20120322789A1 (en) 2012-12-20
CY1113059T1 (el) 2016-04-13
TWI433852B (zh) 2014-04-11
TWI530500B (zh) 2016-04-21
US8198435B2 (en) 2012-06-12
SI1812448T1 (sl) 2012-09-28
BRPI0517689A (pt) 2008-10-14
TNSN07165A1 (en) 2008-11-21
JO2897B1 (en) 2015-09-15
AU2009245817B2 (en) 2013-02-21
CA2584911A1 (en) 2006-05-11
PE20130377A1 (es) 2013-04-03
MY154878A (en) 2015-08-14
JP5057986B2 (ja) 2012-10-24
EP2272850A2 (en) 2011-01-12
KR101333851B1 (ko) 2013-11-27
ES2388142T3 (es) 2012-10-09
NO338960B1 (no) 2016-11-07
MA29033B1 (fr) 2007-11-01
NZ588025A (en) 2012-04-27
RU2007120695A (ru) 2008-12-10
NO20072290L (no) 2007-05-30
PE20090433A1 (es) 2009-05-05
JP2012149099A (ja) 2012-08-09
KR20070083979A (ko) 2007-08-24
IL207702A (en) 2016-09-29
KR101289998B1 (ko) 2013-07-30
US8710216B2 (en) 2014-04-29
PT1812448E (pt) 2012-08-24
TWI455941B (zh) 2014-10-11
NZ599033A (en) 2012-09-28
DK1812448T3 (da) 2012-08-27
EP1812448A1 (en) 2007-08-01
NZ554653A (en) 2010-10-29
AR052322A1 (es) 2007-03-14
NO20161152A1 (no) 2007-05-30
KR20120101601A (ko) 2012-09-13
GT200500311A (es) 2006-05-22
EP2272850B1 (en) 2017-05-10
JP2017061578A (ja) 2017-03-30
KR20120101600A (ko) 2012-09-13
RU2394038C2 (ru) 2010-07-10
JP2015063569A (ja) 2015-04-09
IL217571A (en) 2017-07-31
JP2008518995A (ja) 2008-06-05

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
IL182691A0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0401089D0 (en) Organic compounds
GB0407467D0 (en) Organic compounds
GB0409235D0 (en) Organic compounds
GB0408066D0 (en) Organic compounds
GB0408060D0 (en) Organic compounds
GB0401091D0 (en) Organic compounds
GB0409602D0 (en) Organic compounds